Celon Pharma SA
F:8RP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celon Pharma SA
F:8RP
|
PL |
|
E
|
Emak SpA
F:EK4
|
IT |
|
Origin Energy Ltd
ASX:ORG
|
AU |
|
A
|
Atea ASA
XMUN:MKL
|
NO |
|
Technip Energies NV
F:68F
|
FR |
|
B
|
Billerud AB (publ)
SWB:BNF
|
SE |
|
CubeSmart
NYSE:CUBE
|
US |
|
A
|
Accent Resources NL
ASX:ACS
|
AU |
|
Indonesia Kendaraan Terminal Tbk PT
IDX:IPCC
|
ID |
|
C
|
Constellation Software Inc
XMUN:W9C
|
CA |
|
Technip Energies NV
PAR:TE
|
FR |
|
Celtic PLC
LSE:CCP
|
UK |
|
L
|
Liaoning Port Co Ltd
XMUN:D7P
|
CN |
|
M
|
Morgan Stanley
XMUN:DWD
|
US |
|
S
|
Scor SE
XMUN:SDRC
|
FR |
|
R
|
Ross Stores Inc
XMUN:RSO
|
US |
Intrinsic Value
Is 8RP undervalued or overvalued?
See the intrinsic value estimate for Celon Pharma SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
8RP looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 8RP’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Celon Pharma Does
Celon Pharma SA is a Polish pharmaceutical company that develops, manufactures, and sells medicines. Its business includes both its own drug development programs and established prescription products, with a focus on areas such as nervous system disorders, oncology, and other specialist treatments. It also works with drug substances and manufacturing capabilities that support its own portfolio and outside customers.
- Headquarters
- Poland PL
- Employees
- 566
- IPO date
- Dec 1, 2016
Revenue & Expenses Breakdown
Celon Pharma SA
Earnings Waterfall
Celon Pharma SA
The intrinsic value for Celon Pharma SA (8RP) under the Base Case is hidden EUR.
Compared with the current market price of 4.23 EUR, the stock appears hidden.